新闻中心
内毒素检测新闻中心
新闻中心
科德角国际新闻中心
当前位置:
首页
>
>
>
High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease

High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease

  • 分类:文献资讯
  • 作者:
  • 来源:ScienceDirect
  • 发布时间:2022-01-26 14:00
  • 访问量:

【概要描述】High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease

High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease

【概要描述】High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease

  • 分类:文献资讯
  • 作者:
  • 来源:ScienceDirect
  • 发布时间:2022-01-26 14:00
  • 访问量:
详情

High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease

Highlights

  • This is the first study to assess the use of the β-(1,3)-d-glucan test in cystic fibrosis patients.
  • Glucan antigenemia is common in CF in the absence of invasive fungal disease.
  • Patients with CF-related diabetes have high serum fungal glucan levels.
  • False-positive fungal glucan levels seen in CF patients.

Abstract

β-(1,3)-d-glucan (BDG) is used to rule out invasive fungal disease (IFD) but its usefulness in cystic fibrosis (CF) has not been evaluated. We measured serum BDG in CF patients with no clinical suspicion of IFD. Samples from 46 adult CF patients during a stable period and during pulmonary exacerbation were tested. The association of BDG with clinical variables was analyzed. Three hundred and three non-CF patients with suspected IFD were used as comparators. Both samples were negative in 52% of CF patients, whereas 67% of comparators had only negative results (P = 0.08). CF patients with pancreatic insufficiency and CF-related diabetes had fewer negative results (P < 0.05 for both). Negative results were more common in older CF patients (P < 0.05). Use of antibiotics, presence of fungi in sputum and CF liver disease did not impact BDG levels. In conclusion, patients with CF experience significant BDG antigenaemia in the absence of IFD.

扫二维码用手机看

相关资讯

暂时没有内容信息显示
请先在网站后台添加数据记录。

相关产品

暂时没有内容信息显示
请先在网站后台添加数据记录。

相关文件

暂时没有内容信息显示
请先在网站后台添加数据记录。

资讯推荐

产品推荐

细菌内毒素&葡聚糖检测分析软件_Pyros®eXpress
细菌内毒素&葡聚糖检测分析软件_Pyros®eXpress
美国ACC公司推出的新一代细菌内毒素和葡聚糖检测分析软件,为您的定量内毒素和葡聚糖检测测试、报告需求、趋势和数据管理提供集成解决方案。
细菌内毒素定量检测系统_PKF96
细菌内毒素定量检测系统_PKF96
Pyros Kinetix® Flex是一款新型细菌内毒素定量检测系统,适用于基因重组法/动态显色法/动态浊度法内毒素检测及葡聚糖试剂盒检测实验,仪器包括32, 64, 96孔三种型号,符合USP,EP,JP细菌内毒素检测标准。
基因重组鲎试剂_PNG050-2
基因重组鲎试剂_PNG050-2
PyroSmart NextGenTM(PSNG)基因重组鲎试剂是一种基因工程合成的细菌内毒素定量检测试剂,不依赖天然鲎血,满足可持续发展的目标,可以应用动态显色法进行测试和分析。
显色法鲎试剂_CG1500
显色法鲎试剂_CG1500
细菌内毒素检测显色法试剂盒是一款多功能高灵敏度的细菌内毒素检测试剂,可用于动态显色法检测和终点显色法检测
浊度法鲎试剂_T0051
浊度法鲎试剂_T0051
Pyrotell®-T浊度法鲎试剂是一款定量检测细菌内毒素的产品,配合专用仪器(如PKF32/64/96)可用于动态浊度法及终点浊度法的内毒素检测实验。该产品已获得美国FDA认证

底部联系方式信息(左)

发布时间:2022-01-27 11:34:07

 

400-687-1881

公司电话:010-87875910

公司邮箱:info@bio-life.cn

公司官网:www.acciusa.cn  www.bio-life.cn

公司地址:北京市大兴区中关村科技园区大兴生物

医药产业基地华佗路50号院18幢(中国药谷CBP)

这是描述信息

关注官方微信

这是描述信息

关注手机网站